Jun Liang
Zhejiang Chinese Medical University(CN)Guangxi Medical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Dongguan University of Technology(CN)Guilin University of Technology(CN)National Cancer Center(US)Peking University Cancer Hospital(CN)Fanjingshan National Nature Reserve(CN)Ningxia Hui Autonomous Region Peoples Hospital(CN)Schlumberger (Ireland)(IE)First Affiliated Hospital of GuangXi Medical University(CN)Ningxia Medical University(CN)Peking University International Hospital(CN)Ningxia Medical University General Hospital(CN)Community Health Center(US)Ministry of Education(ET)Thornton Tomasetti (United States)(US)Second Affiliated Hospital of Zhejiang University(CN)The Fourth People's Hospital of Ningxia Hui Autonomous Region(CN)Guilin University of Electronic Technology(CN)Jiangxi Normal University(CN)China National Petroleum Corporation (China)(CN)
Publications by Year
Research Areas
Thyroid Cancer Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Cancer Mechanisms and Therapy, Thyroid Disorders and Treatments, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)(2020)818 cited
- → Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)(2018)684 cited
- → Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study(2023)612 cited
- → Hepatogastroenterology(2011)396 cited
- → Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer(2023)318 cited
- → CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma(2022)131 cited